Case C-614/16 P: Judgment of the Court (Fourth Chamber) of 25 March 2021 — Merck KGaA v European Commission, Generics (UK) Ltd (Appeal — Competition — Agreements, decisions and concerted practices — Pharmaceutical products — Market for antidepressant medicines (citalopram) — Settlement agreements concerning process patents concluded between a manufacturer of originator medicines holding those patents and manufacturers of generic medicines — Article 101 TFEU — Potential competition — Restriction by object — Characterisation — Calculation of the amount of the fine)

Maintenance EN

Please note that this website will be undergoing technical maintenance between 28 and 31 August. Consequently, users may experience instabilities and limited functionality. We apologise for the inconvenience.

Web Content Display (Global)

Publication Detail Actions Portlet


Publication Detail Portlet

Publication detail


Publication Viewer

Document viewer

The document doesn't have a viewable format at this time

Go Back Widget